Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $2.9 million.

  • Angiodynamics' Net Cash Flow rose 58248.77% to $2.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$13.2 million, marking a year-over-year decrease of 10114.66%. This contributed to the annual value of -$20.6 million for FY2025, which is 16566.7% down from last year.
  • Angiodynamics' Net Cash Flow amounted to $2.9 million in Q4 2025, which was up 58248.77% from -$17.3 million recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Net Cash Flow peaked at $17.6 million during Q1 2024, and registered a low of -$21.2 million during Q3 2024.
  • Over the past 5 years, Angiodynamics' median Net Cash Flow value was -$788500.0 (recorded in 2021), while the average stood at -$830650.0.
  • Examining YoY changes over the last 5 years, Angiodynamics' Net Cash Flow showed a top increase of 1054969.7% in 2024 and a maximum decrease of 26341.39% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Net Cash Flow stood at -$966000.0 in 2021, then surged by 628.57% to $5.1 million in 2022, then tumbled by 38.88% to $3.1 million in 2023, then crashed by 119.58% to -$611000.0 in 2024, then skyrocketed by 582.49% to $2.9 million in 2025.
  • Its Net Cash Flow was $2.9 million in Q4 2025, compared to -$17.3 million in Q3 2025 and $10.4 million in Q2 2025.